Skip to content

TOP FARMA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

TOP FARMA

BE 0423.367.188
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€150,921
2024 · €186,883-€35,962
Equity
€546,762
2024 · €395,841+€150,921
Cash
€294,787
2024 · €312,135-€17,347
Balance sheet total
€792,445
2024 · €780,373+€12,072

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€65,850

    up €65,850 (+35.2%), from €187,312 to €253,162

    of which Trade receivables: +€35,034

  • Tangible fixed assets -€23,928

    down €23,928 (-39.9%), from €59,993 to €36,066

    of which Furniture and vehicles: -€15,661

  • Cash -€17,347

    down €17,347 (-5.6%), from €312,135 to €294,787

    mainly Other debts (-€181,979) and Receivables within one year (-€65,850)

  • Stocks and contracts -€12,582

    down €12,582 (-5.9%), from €214,220 to €201,638

Equity and liabilities
  • Other debts -€181,979

    down €181,979 (-99.9%), from €182,197 to €218

  • Reserves +€150,921

    up €150,921 (+45.2%), from €333,868 to €484,789

    of which Distributable reserves: +€150,921

  • Trade debts +€56,513

    up €56,513 (+35.9%), from €157,476 to €213,989

  • Tax, wage and social debts -€13,384

    down €13,384 (-29.8%), from €44,860 to €31,476

    of which Taxes: -€22,324

Income statement
  • Gross operating margin -€56,707

    down €56,707 (-12.4%), from €458,073 to €401,366

  • Staff costs +€18,721

    up €18,721 (+13.0%), from €144,034 to €162,755

  • Financial charges -€17,343

    down €17,343 (-61.0%), from €28,415 to €11,072

  • Taxes -€11,899

    down €11,899 (-18.5%), from €64,156 to €52,256

  • Depreciation -€10,051

    down €10,051 (-28.6%), from €35,148 to €25,098

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €186,883
Gross operating margin -€56,707
Staff costs -€18,721
Depreciation +€10,051
Other operating charges -€26
Financial income +€198
Financial charges +€17,343
Taxes +€11,899
Result 2025 €150,921
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€16,177
Investment -€1,170
Financing €0
Cash 2024 €312,135
Net result for the year +€150,921
Depreciation +€25,098
Stocks and contracts +€12,582
Receivables within one year -€65,850
Deferred charges and accrued income -€79
Trade debts +€56,513
Tax, wage and social debts -€13,384
Other debts -€181,979
Investment in fixed assets (net) -€1,170
Cash 2025 €294,787
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €780,373 €792,445 +€12,072 +1.5%
Fixed assets 21/28 €59,993 €36,066 -€23,928 -39.9%
Intangible fixed assets 21 €0 - =
Tangible fixed assets 22/27 €59,993 €36,066 -€23,928 -39.9%
Plant, machinery and equipment 23 €22,186 €13,919 -€8,267 -37.3%
Furniture and vehicles 24 €37,808 €22,146 -€15,661 -41.4%
Current assets 29/58 €720,380 €756,380 +€36,000 +5.0%
Stocks and contracts in progress 3 €214,220 €201,638 -€12,582 -5.9%
Stocks 30/36 €214,220 €201,638 -€12,582 -5.9%
Amounts receivable within one year 40/41 €187,312 €253,162 +€65,850 +35.2%
Trade receivables 40 €184,172 €219,206 +€35,034 +19.0%
Other amounts receivable 41 €3,140 €33,957 +€30,816 +981%
Cash at bank and in hand 54/58 €312,135 €294,787 -€17,347 -5.6%
Deferred charges and accrued income 490/1 €6,713 €6,792 +€79 +1.2%
Total equity and liabilities 10/49 €780,373 €792,445 +€12,072 +1.5%
Equity 10/15 €395,841 €546,762 +€150,921 +38.1%
Contributions 10/11 €61,973 €61,973 = 0.0%
Capital 10 €61,973 €61,973 = 0.0%
Issued capital 100 €61,973 €61,973 = 0.0%
Reserves 13 €333,868 €484,789 +€150,921 +45.2%
Non-distributable reserves 130/1 €6,197 €6,197 = 0.0%
Legal reserve 130 €6,197 €6,197 = 0.0%
Distributable reserves 133 €327,671 €478,592 +€150,921 +46.1%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €384,532 €245,683 -€138,849 -36.1%
Amounts payable within one year 42/48 €384,532 €245,683 -€138,849 -36.1%
Trade debts 44 €157,476 €213,989 +€56,513 +35.9%
Suppliers 440/4 €157,476 €213,989 +€56,513 +35.9%
Taxes, remuneration and social security 45 €44,860 €31,476 -€13,384 -29.8%
Taxes 450/3 €27,018 €4,694 -€22,324 -82.6%
Remuneration and social security 454/9 €17,841 €26,782 +€8,940 +50.1%
Other amounts payable 47/48 €182,197 €218 -€181,979 -99.9%
Remuneration, social security and pensions 62 €144,034 €162,755 +€18,721 +13.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €35,148 €25,098 -€10,051 -28.6%
Other operating charges 640/8 €892 €917 +€26 +2.9%
Gross operating margin 9900 €458,073 €401,366 -€56,707 -12.4%
Operating profit (loss) 9901 €277,998 €212,595 -€65,403 -23.5%
Financial income 75/76B €1,456 €1,654 +€198 +13.6%
Recurring financial income 75 €1,456 €1,654 +€198 +13.6%
Financial charges 65/66B €28,415 €11,072 -€17,343 -61.0%
Recurring financial charges 65 €28,415 €11,072 -€17,343 -61.0%
Profit (loss) for the period before taxes 9903 €251,039 €203,177 -€47,862 -19.1%
Income taxes 67/77 €64,156 €52,256 -€11,899 -18.5%
Profit (loss) for the period 9904 €186,883 €150,921 -€35,962 -19.2%
Profit (loss) for the period to be appropriated 9905 €186,883 €150,921 -€35,962 -19.2%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.